Servier Pharmaceuticals LLC

Boston, MA

UEI
G3YUU3BJQNL4
CAGE
8HTU0
Primary NAICS
325412 Pharmaceutical Preparation Manufacturing
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
200 Pier Four Blvd, Boston, MA 02210, USA
Website
servier.us
Founded
2018
Employees
251-1K
Estimated annual revenue
$100M-$250M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract vehicles

Contract awards

Latest 5 listed here. See the rest on GovTribe.

Similar vendors

About the company

Servier Pharmaceuticals LLC is a for-profit corporate entity that provides pharmaceutical drugs and biological products to U.S. government agencies, primarily the Department of Veterans Affairs (VA), through various federal contract vehicles.

Past prime federal contract awards to Servier have been for the supply of specialty oncology medications such as pegaspargase (Oncaspar) and asparlas to support healthcare services for veterans under VA programs. The awards have included delivery orders placed against Servier's Federal Supply Schedule contract, as well as calls issued under a $10 million blanket purchase agreement with the VA National Acquisition Center. The contracts were predominantly firm-fixed price awards with no set-aside designation. Servier has provided the pharmaceuticals to VA Veterans Integrated Service Networks across the country, with places of performance in states such as Tennessee, California, Michigan, and Massachusetts.

Servier holds several indefinite-delivery vehicles with the VA and General Services Administration to provide pharmaceuticals. These include a $19 million Federal Supply Schedule contract for drugs, pharmaceuticals and hematology products, awarded in 2020. Delivery orders have been placed against this schedule by VA Networks for Servier's oncology medications. Additionally, Servier was awarded a $10 million blanket purchase agreement in 2020 by the VA National Acquisition Center to supply asparlas and oncaspar over five years. The BPA aims to streamline procurement of these specialty chemotherapy agents to support cancer treatment programs for veterans. Further, Servier previously held a separate $12 million blanket purchase agreement, awarded in 2020 by the National Acquisition Center, focused specifically on procuring the cancer drugs asparlas and oncaspar.

Quick answers

Is Servier Pharmaceuticals LLC registered in SAM.gov?

Yes. Servier Pharmaceuticals LLC's SAM.gov registration is active through March 27, 2027.

What is Servier Pharmaceuticals LLC's CAGE code?

Servier Pharmaceuticals LLC's CAGE code is 8HTU0, and its Unique Entity ID (UEI) is G3YUU3BJQNL4.

Which contract vehicles does Servier Pharmaceuticals LLC hold?

Servier Pharmaceuticals LLC holds a place on 1 federal contract vehicle: FSS-61-IB.

What is Servier Pharmaceuticals LLC's most recent federal award?

Servier Pharmaceuticals LLC's most recent federal contract award is 1 pegaspargase 750U (ONCASPAR) (36C26222F0068), from Veterans Integrated Service Network 22 (VHA), on November 4, 2021.

On GovTribe

See Servier Pharmaceuticals LLC's full federal record

  • Federal contract awards
  • IDV awards
  • Contract vehicles
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors

Find teaming partners on GovTribe